08-Dec-15 China's implementation of healthcare reforms, changing the approval process for new medical devices and favoring local manufacturers will restrain growth for US medical manufacturers, says Moody's. China's healthcare reforms will be particularly credit negative for companies that make complex devices, such as Medtronic, Boston Scientific and St Jude. [image: Shannon Stapleton / Reuters]

13-Oct-15 As China's growing 40+ population suffers increasingly from lifestyle diseases such as cardiac problems and cancer, many of the wealthy among them will seek treatment in the US or Europe. And many more will spend some of their new found wealth on plastic surgery, dentistry or wellness programs in Korea or Southeast Asia. Chinese medical tourists spent USD10 bn in 2014, only 2.3% of the global total, suggesting that there is a huge potential for further growth in the market. What can hospitals and governments do to tap into this opportunity? [image: Travel Daily News]

03-Nov-15 Chinese diabetes tech firm Sinocare has signed an agreement to acquire Nipro Diagnostics from Japan's Nipro Corp, for USD273 mn. Nipro Diagnostics is based in Florida and manufacturers products for people with diabetes, including a portfolio of blood glucose monitoring technologies. Sinocare CEO Shaobo Li said “Diabetes has become one of the biggest challenges to our public healthcare system and society." [image: Sinocare]

29-Jul-15 Raffles Medical Group, a major Singaporean private healthcare provider, has joined the Mayo Clinic Care Network. By joining the network, Raffles Medical's health specialists can seek advice from Mayo Clinic's physicians in the network on treatments and disease management. Physicians and specialists in the network can also share their expertise via online conferences to discuss medical issues. [image: Mayo Clinic Care Network]

23-Jul-15 Korea's Ministry of Health & Welfare compared the Korean National Health Accounts and Total Health Expenditure data for 2014 to the OECD’s Health Data and announced that the Korean government’s public financial resources accounted for 55% of the country’s national health expenditures. Conversely, the average of the 34 OECD member countries was as high as 72%. [image: Business Korea]